Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-20-011428)

Filing Details

Accession Number:: 0001179110-20-011428
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-25 18:59:00
Reporting Period:: 2020-11-25

Accepted Time:: 2020-11-25 18:59:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159036	Halozyme Therapeutics Inc.	HALO	Biological Products, (No Disgnostic Substances) (2836)	880488686

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1324015	William Jeffrey Henderson	C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-11-25	24,498	$40.08	47,609	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents a weighted average sales price per share. These shares were sold at prices ranging from $40.07 to $40.11. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.